Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,413,000 | 6,635,000 | 6,635,000 | 4,296,200 | 4,589,190 |
| Marketable Securities | N/A | 6,367,000 | 6,367,000 | 6,872,140 | 5,188,110 |
| Receivables | 3,191,000 | 3,184,000 | 3,184,000 | 4,816,040 | 4,011,660 |
| Inventories | 2,583,000 | 2,448,000 | 2,448,000 | 4,710,700 | 4,619,550 |
| Other current assets | 1,233,000 | 1,723,000 | 1,723,000 | 7,321,560 | 2,259,060 |
| TOTAL | $19,420,000 | $20,357,000 | $20,357,000 | $28,016,640 | $20,667,570 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 3,997,000 | 3,997,000 | 5,412,490 | 4,565,730 |
| Other Non-Current Assets | 19,643,000 | 10,006,000 | 10,006,000 | 3,411,781 | 5,715,270 |
| TOTAL | $19,643,000 | $14,003,000 | $14,003,000 | $8,824,271 | $10,281,000 |
| Total Assets | $39,063,000 | $39,753,000 | $39,753,000 | $44,820,460 | $38,795,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,058,000 | 0 | 3,020,000 | 0 | 0 |
| Accounts payable and accrued liabilities | 922,000 | 1,077,000 | 1,077,000 | 11,910,490 | 10,343,100 |
| Other current liabilities | 4,137,000 | 4,373,000 | 4,373,000 | 0 | 0 |
| TOTAL | $8,117,000 | $8,470,000 | $8,470,000 | $11,910,490 | $10,343,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,485,000 | 1,483,000 | 1,483,000 | 1,671,690 | 1,958,910 |
| Other Non-Current Liabilities | 4,775,000 | 2,342,000 | 2,342,000 | 3,137,500 | 2,872,470 |
| TOTAL | $6,261,000 | $6,137,000 | $6,137,000 | $7,303,050 | $6,788,910 |
| Total Liabilities | $14,378,000 | $14,607,000 | $14,607,000 | $19,213,560 | $17,132,010 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 859,000 | 859,000 | 1,138,170 | 995,670 |
| Retained earnings | N/A | 24,387,000 | 0 | 0 | 0 |
| Other shareholders' equity | 24,685,000 | 0 | 24,387,000 | 24,557,730 | 20,746,570 |
| TOTAL | $24,685,000 | $25,146,000 | $25,146,000 | $25,606,900 | $21,663,240 |
| Total Liabilities And Equity | $39,063,000 | $39,753,000 | $39,753,000 | $44,820,460 | $38,795,250 |